SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '9ZP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OPJ_B_STIB4_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 6 | LEU A 68LYS A 91ILE A 137ARG A 184 | 9ZP A1333 (-3.9A)NoneNoneNone | 1.07A | 1opjB-4b6lA:22.6 | 1opjB-4b6lA:26.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89GLU A 110CYH A 142LEU A 176HIS A 183GLY A 202 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)NoneNone9ZP A1333 ( 4.4A) | 0.56A | 1uwhA-4b6lA:24.5 | 1uwhA-4b6lA:27.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89GLU A 110LEU A 176HIS A 183GLY A 202PHE A 192 | 9ZP A1333 (-3.5A)NoneNoneNone9ZP A1333 ( 4.4A)9ZP A1333 (-3.6A) | 1.28A | 1uwhA-4b6lA:24.5 | 1uwhA-4b6lA:27.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ALA A 89LYS A 91GLU A 110CYH A 142LEU A 176HIS A 183GLY A 202 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-4.1A)NoneNone9ZP A1333 ( 4.4A) | 0.60A | 1uwhB-4b6lA:24.3 | 1uwhB-4b6lA:27.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89GLU A 110CYH A 142LEU A 176HIS A 183GLY A 202 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)NoneNone9ZP A1333 ( 4.4A) | 0.56A | 1uwjA-4b6lA:6.6 | 1uwjA-4b6lA:27.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89GLU A 110CYH A 142LEU A 176HIS A 183GLY A 202 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)NoneNone9ZP A1333 ( 4.4A) | 0.56A | 1uwjB-4b6lA:6.6 | 1uwjB-4b6lA:27.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HYY_A_STIA600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 6 | LEU A 68VAL A 123ILE A 137ARG A 184 | 9ZP A1333 (-3.9A)9ZP A1333 (-4.4A)NoneNone | 0.85A | 2hyyA-4b6lA:23.0 | 2hyyA-4b6lA:26.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AOX_A_EMHA901_1 (ALK TYROSINE KINASERECEPTOR) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 10 | ARG A 66LEU A 68ALA A 89LYS A 91VAL A 123LEU A 139LEU A 141 | 9ZP A1333 (-3.3A)9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)None9ZP A1333 (-4.4A)9ZP A1333 (-3.8A)9ZP A1333 (-4.7A) | 0.72A | 3aoxA-4b6lA:23.5 | 3aoxA-4b6lA:24.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | LEU A 68GLY A 69ALA A 89LYS A 91VAL A 123CYH A 142 | 9ZP A1333 (-3.9A)9ZP A1333 (-3.6A)9ZP A1333 (-3.5A)None9ZP A1333 (-4.4A)9ZP A1333 (-4.1A) | 0.58A | 3c7qA-4b6lA:22.2 | 3c7qA-4b6lA:25.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXZ_A_0LIA1_2 (TYROSINE-PROTEINKINASE ABL1) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 9 | LEU A 68LYS A 91ILE A 137ARG A 184VAL A 201 | 9ZP A1333 (-3.9A)NoneNoneNoneNone | 1.01A | 3oxzA-4b6lA:22.8 | 3oxzA-4b6lA:25.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PYY_A_STIA3_2 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 6 | LYS A 91VAL A 123ILE A 137ARG A 184 | None9ZP A1333 (-4.4A)NoneNone | 1.08A | 3pyyA-4b6lA:22.5 | 3pyyA-4b6lA:24.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZBF_A_VGHA3000_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | LEU A 68ALA A 89LEU A 139LEU A 141GLY A 202ASP A 203 | 9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)9ZP A1333 (-3.8A)9ZP A1333 (-4.7A)9ZP A1333 ( 4.4A)None | 0.62A | 3zbfA-4b6lA:25.5 | 3zbfA-4b6lA:24.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | LEU A 68ALA A 89LYS A 91LEU A 139LEU A 141ASP A 203 | 9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)None9ZP A1333 (-3.8A)9ZP A1333 (-4.7A)None | 0.51A | 4mkcA-4b6lA:24.5 | 4mkcA-4b6lA:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MM4_A_8PRA603_1 (TRANSPORTER) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 12 | VAL A 90ALA A 89TYR A 88SER A 126THR A 54 | None9ZP A1333 (-3.5A)NoneNoneNone | 1.33A | 4mm4A-4b6lA:undetectable | 4mm4A-4b6lA:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MM4_B_8PRB603_1 (TRANSPORTER) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 12 | VAL A 90ALA A 89TYR A 88SER A 126THR A 54 | None9ZP A1333 (-3.5A)NoneNoneNone | 1.31A | 4mm4B-4b6lA:undetectable | 4mm4B-4b6lA:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OGR_E_ADNE401_1 (CYCLIN-DEPENDENTKINASE 9) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 7 | ALA A 89CYH A 142ASN A 190ASP A 203 | 9ZP A1333 (-3.5A)9ZP A1333 (-4.1A)NoneNone | 0.22A | 4ogrE-4b6lA:28.9 | 4ogrE-4b6lA:29.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_A_032A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91ILE A 137SER A 146PHE A 192GLY A 202 | 9ZP A1333 (-3.5A)NoneNoneNone9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.61A | 4rzvA-4b6lA:23.9 | 4rzvA-4b6lA:29.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_A_032A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91SER A 146PHE A 192GLY A 202PHE A 204 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)None | 0.92A | 4rzvA-4b6lA:23.9 | 4rzvA-4b6lA:29.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_B_032B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202GLY A 205 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)None | 1.36A | 4rzvB-4b6lA:23.2 | 4rzvB-4b6lA:29.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_B_032B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202PHE A 204 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)None | 0.97A | 4rzvB-4b6lA:23.2 | 4rzvB-4b6lA:29.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_B_032B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91CYH A 142SER A 146PHE A 192GLY A 202 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)None9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.65A | 4rzvB-4b6lA:23.2 | 4rzvB-4b6lA:29.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202ASP A 203PHE A 204 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)NoneNone | 0.74A | 4xv2A-4b6lA:24.2 | 4xv2A-4b6lA:28.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202ASP A 203PHE A 204 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)NoneNone | 0.72A | 4xv2B-4b6lA:24.5 | 4xv2B-4b6lA:28.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202PHE A 204 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)None | 0.76A | 5cswA-4b6lA:24.0 | 5cswA-4b6lA:28.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | ALA A 89LYS A 91CYH A 142PHE A 192GLY A 202PHE A 204 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A)None | 0.79A | 5cswB-4b6lA:24.0 | 5cswB-4b6lA:28.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_B_1N1B501_1 (PROTEIN-TYROSINEKINASE 6) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | LEU A 68ALA A 89ILE A 137LEU A 141GLY A 202ASP A 203 | 9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)None9ZP A1333 (-4.7A)9ZP A1333 ( 4.4A)None | 0.78A | 5h2uB-4b6lA:24.6 | 5h2uB-4b6lA:28.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HI2_A_BAXA801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ALA A 89LYS A 91GLU A 110CYH A 142LEU A 176HIS A 183GLY A 202 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-4.1A)NoneNone9ZP A1333 ( 4.4A) | 0.66A | 5hi2A-4b6lA:24.4 | 5hi2A-4b6lA:27.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 12 | ALA A 89LYS A 91ILE A 137PHE A 192GLY A 202 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.78A | 5hieA-4b6lA:23.1 | 5hieA-4b6lA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 12 | ALA A 89LYS A 91ILE A 137PHE A 192GLY A 202 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.81A | 5hieB-4b6lA:8.4 | 5hieB-4b6lA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_D_P06D801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 5 / 12 | ALA A 89LYS A 91ILE A 137PHE A 192GLY A 202 | 9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.78A | 5hieD-4b6lA:23.2 | 5hieD-4b6lA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OWR_A_1N1A401_1 (SERINE/THREONINE-PROTEIN KINASE 10) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 8 | ALA A 89GLU A 110CYH A 142ASP A 203 | 9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)None | 0.43A | 5owrA-4b6lA:24.2 | 5owrA-4b6lA:28.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VC3_A_DB8A601_1 (WEE1-LIKE PROTEINKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 6 / 12 | GLY A 69ALA A 89GLU A 110CYH A 142PHE A 192ASP A 203 | 9ZP A1333 (-3.6A)9ZP A1333 (-3.5A)None9ZP A1333 (-4.1A)9ZP A1333 (-3.6A)None | 0.83A | 5vc3A-4b6lA:28.1 | 5vc3A-4b6lA:28.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCV_A_1N1A404_1 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | LEU A 68ALA A 89LYS A 91GLU A 110VAL A 123PHE A 192GLY A 202 | 9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-4.4A)9ZP A1333 (-3.6A)9ZP A1333 ( 4.4A) | 0.65A | 5vcvA-4b6lA:27.0 | 5vcvA-4b6lA:29.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCV_A_1N1A404_2 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 5 | HIS A 114LEU A 141CYH A 142ASP A 203 | None9ZP A1333 (-4.7A)9ZP A1333 (-4.1A)None | 0.72A | 5vcvA-4b6lA:27.0 | 5vcvA-4b6lA:29.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 4 / 4 | VAL A 123LEU A 141ASN A 190ASP A 203 | 9ZP A1333 (-4.4A)9ZP A1333 (-4.7A)NoneNone | 0.79A | 5vcyA-4b6lA:26.9 | 5vcyA-4b6lA:29.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ARG A 66LEU A 68ALA A 89LYS A 91GLU A 110LEU A 141CYH A 142 | 9ZP A1333 (-3.3A)9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-4.7A)9ZP A1333 (-4.1A) | 0.74A | 5y7zA-4b6lA:28.2 | 5y7zA-4b6lA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
4b6l | SERINE/THREONINE-PROTEIN KINASE PLK3 (Homosapiens) | 7 / 12 | ARG A 66LEU A 68ALA A 89LYS A 91GLU A 110LEU A 141CYH A 142 | 9ZP A1333 (-3.3A)9ZP A1333 (-3.9A)9ZP A1333 (-3.5A)NoneNone9ZP A1333 (-4.7A)9ZP A1333 (-4.1A) | 0.74A | 5y7zA-4b6lA:28.2 | 5y7zA-4b6lA:28.04 |